Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.
Business Of Biotech
00:00
Origins and Challenges of Mythic Therapeutics
The chapter delves into the origin story of Mythic Therapeutics, where former associates ventured into the biotech industry with a focus on ADCs. It discusses the challenges faced in selling their paradigm-shifting concept in 2017 and the necessity to convince skeptics of the idea's value. Mythic Therapeutics' unique strategic focus on developing ADCs that efficiently target cancer cells while sparing normal cells is highlighted, alongside the current challenges facing ADCs in oncology.
Transcript
Play full episode
